NTAP Selected as Innovator Presenter for Partnering for Cures Meeting

Baltimore, MD (October 1, 2014) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced that they have been selected as an Innovator Presenter at the 6th Annual Partnering for Cures meeting to be held in New York, NY, on November 16 – 18, 2014. This meeting is convened by FasterCures, a centre of the Milken Institute, which […]

Johns Hopkins Announces Winners of Francis S. Collins Scholar Award

Baltimore, MD (June 9, 2014) Two early career physician-scientists, Peter de Blank and Matthew R. Steensma, have been named inaugural winners of the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, sponsored by the Neurofibromatosis Therapeutic Acceleration Program (NTAP) at The Johns Hopkins University. The program will create a community of expert […]

NTAP Announces Request for Proposals to Develop Patient Reported Outcome Measures

Baltimore, MD (March 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of Patient Reported Outcome (PRO) measures that can be used to support clinical development of therapies against plexiform neurofibromas (pNFs), one of the most common tumors seen in individuals with neurofibromatosis type 1 (NF1). PROs […]

NTAP Announces Biomarker Development Idea Challenge

Baltimore, MD (January 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced the launch of an idea challenge for the development of biomarkers for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Individuals with pNF can have multiple tumors that vary greatly in terms of how they progress. PNFs can grow to substantial volume over time, […]

NTAP Announces Request for Proposals to Develop Cell Culture Models of Plexiform Neurofibromas

Baltimore, MD (October 1, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of novel cell culture models for neurofibromatosis type 1 (NF1)-associated [...]

NTAP hosts 2012 Plexiform Neurofibroma Research Summit

Baltimore, MD (September 22, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) held its inaugural Plexiform Neurofibroma Scientific Summit on September 20-22, 2012. Held at Nemacolin Woodlands Resort, the summit focused on [...]

NTAP announces launch of operations

Baltimore, MD (June 8, 2012) Today, the Neurofibromatosis Therapeutic Acceleration Program (NTAP) announced the launch of its operations, dedicated to improving treatment options for individuals with plexiform neurofibromas (pNFs). NTAP [...]

News